The global radiopharmaceuticals market is expected to grow from USD 3,365.65 million 2017 to USD 4,962.55 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 5.70%.

On the basis of procedural volume, the global radiopharmaceuticals market is studied across Alpha Emitters, Beta Emitters, Brachytherapy Isotopes, Pet Radiopharmaceuticals, and Spect Radiopharmaceuticals.

On the basis of type, the global radiopharmaceuticals market is studied across Alpha Emitters, Beta Emitters, Brachytherapy Isotopes, Pet Radiopharmaceuticals, and Spect Radiopharmaceuticals.

On the basis of application, the global radiopharmaceuticals market is studied across Bone Metastasis, Cardiology, Endocrine Tumors, Lymphoma, Neurology, Oncology, and Thyroid.

On the basis of end user, the global radiopharmaceuticals market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Centers, and Hospitals.

On the basis of geography, the global radiopharmaceuticals market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

"Advanced Accelerator Applications: The potential growing player for the global radiopharmaceuticals market"

The key players profiled in the global radiopharmaceuticals market are Advanced Accelerator Applications, Bayer, Bracco Imaging, Cardinal Health, Curium, Eckert & Ziegler, Eczacibasi-Monrol Nuclear Products, Ge Healthcare, IBA Radiopharma Solutions, Lantheus Medical Imaging, Mallinckrodt plc., Nordion, Positron Corporation, and Siemens Healthineers.


The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global radiopharmaceuticals market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global radiopharmaceuticals market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global radiopharmaceuticals market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global radiopharmaceuticals market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global radiopharmaceuticals market.